FindTrial
Sign In

Betaloc ZOK 100

DRUG2 trials

Sponsors

Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy, Medical University Of Gdansk

Conditions

000 people may be affected by HCM3) and all-cause mortality (RR 2.5; 95% CI 1.8-3.4) with a mean follow-up of 7 years. HenceAF occurence is even higherDuchenne muscular dystrophy; Cardiomyopathy; TachycardiaHCM is likely to affect around 20 million peopleHypertrophic cardiomyopathy (HCM) is the most common genetically determined disease of the heartand affects both genders equally. Hypertrophic cardiomyopathy is an inherited disease in an autosomal dominant manner and is most often associated with mutations in one of described several genes coding for sarcomere proteins. Atrial fibrillation (AF) occurs in 20-25% of patients with hypertrophic cardiomyopathyand only a part of them is diagnosed

Phase 3

The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study
CompletedCTIS2024-515057-19-00
Medical University Of GdanskDuchenne muscular dystrophy; Cardiomyopathy; Tachycardia
Start: 2021-07-12End: 2025-10-06Target: 144Updated: 2024-12-16

Phase 4

Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
CompletedCTIS2023-508743-43-00
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy000 people may be affected by HCM, 3) and all-cause mortality (RR 2.5; 95% CI 1.8-3.4) with a mean follow-up of 7 years. Hence, AF occurence is even higher +25
End: 2025-09-16Target: 725Updated: 2024-09-16